Recombinant human respiratory syncytial virus (RSV)
monoclonal antibody Fab is effective therapeutically when introduced directly
into the lungs of RSV-infected mice.
J E Crowe, Jr, B R Murphy, R M Chanock, R A Williamson, C F Barbas, 3rd, D R Burton;J E Crowe, Jr;B R Murphy;R M Chanock;R A Williamson;C F Barbas, 3rd;D R Burton;
Proceedings of the National Academy of Sciences of the United States of America1994Vol. 91pp. 1386-
185
burton1994proceedingsrecombinant
Abstract
Previously, recombinant human respiratory
syncytial virus (RSV) monoclonal antibody Fabs were generated by antigen
selection from random combinatorial libraries displayed at the tip of
filamentous phage. Two such Fabs, which exhibited high binding affinity ...